Ⅱ~Ⅳ期乳腺癌患者中Panagen激活继发性免疫反应和白细胞活性的Ⅱ期多中心双盲安慰剂对照临床研究
Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer
未经授权，不得转载，摘编本刊文章，不得使用本刊的版式设计。
申明：本刊刊出的所有文章不代表本刊主办单位和编委会的观点。
下载: